Orange Book product · Generic (ANDA)
FLUOROURACIL
FLUOROURACIL
At a glance
Nov 05, 2003
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 05, 2003
22 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUOROURACIL
Strength
2%
Dosage form
SOLUTION
Route
TOPICAL
TE code
AT
Application
ANDA 076526
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUOROURACIL
- 2026FAVLYXABrand (NDA)
NDA 220201 · AVYXA HOLDINGS
- 2016FLUOROURACILBrand (NDA)
NDA 012209 · SPECTRUM PHARMS
- 2015TOLAKBrand (NDA)
NDA 022259 · HILL DERMACEUTICALS
- 2000CARACBrand (NDA)
NDA 020985 · EXTROVIS
- —EFUDEXBrand (NDA)
NDA 016831 · EXTROVIS
- —FLUOROPLEXBrand (NDA)
NDA 016988 · CHARTWELL RX
- —ADRUCILBrand (NDA)
NDA 017959 · PHARMACIA AND UPJOHN
- —FLUOROPLEXBrand (NDA)
NDA 016765 · ELORAC
- 2025FLUOROURACILGeneric (ANDA)
ANDA 216942 · ENCUBE
- 2025FLUOROURACILGeneric (ANDA)
ANDA 215699 · KINDOS
- 2024FLUOROURACILGeneric (ANDA)
ANDA 216494 · KINDOS
- 2023FLUOROURACILGeneric (ANDA)
ANDA 215612 · ENCUBE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
